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Background: The extracellular matrix plays a critical role in insuring tissue integrity and water homeostasis.
However, breakdown products of the extracellular matrix have emerged as endogenous danger signals, designed
to rapidly activate the immune system against a potential pathogen breach. Type I interferons play a critical role in
the immune response against viral infections. In the lungs, hylauronan (HA) exists as a high molecular weight,
biologically inert extracellular matrix component that is critical for maintaining lung function. When lung tissue is
injured, HA is broken down into lower molecular weight fragments that alert the immune system to the breach in
tissue integrity by activating innate immune responses. HA fragments are known to induce inflammatory gene
expression via TLR-MyD88-dependent pathways.
Methods: Primary peritoneal macrophages from C57BL/6 wild type, TLR4 null, TLR3 null, MyD88 null, and TRIF null
mice as well as alveolar and peritoneal macrophage cell lines were stimulated with HA fragments and cytokine
production was assessed by rt-PCR and ELISA. Western blot analysis for IRF3 was preformed on cell lysates from
macrophages stimulate with HA fragments
Results: We demonstrate for the first time that IFNβ is induced in murine macrophages by HA fragments. We also
show that HA fragments induce IFNβ using a novel pathway independent of MyD88 but dependent on TLR4 via
TRIF and IRF-3.
Conclusions: Overall our findings reveal a novel signaling pathway by which hyaluronan can modulate
inflammation and demonstrate the ability of hyaluronan fragments to induce the expression of type I interferons in
response to tissue injury even in the absence of viral infection. This is independent of the pathway of the TLR2-MyD88
used by these matrix fragments to induce inflammatory chemokines. Thus, LMW HA may be modifying the
inflammatory milieu simultaneously via several pathways.
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The type I interferons have been implicated in a wide
variety of host defense responses [1]. Though there are
many type I interferons in humans (α, β, ω, κ, ε), IFNβ
and IFNα are the best described [1]. Multiple cell types
produce each interferon, making the original distinction
between “leukocyte” IFN (alpha) and fibroblast IFN
(beta) obsolete [1]. These type I interferons share a com-
mon receptor, the interferon-α/β receptor [1]. IFNs* Correspondence: mhorton2@jhmi.edu
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reproduction in any medium, provided the orinduce antiviral cellular responses to diverse stimuli,
including LPS, Shigella, Plasmodium, Schistomsoma,
Mycoplasma, trypanosomes, as well as viruses such as
RSV [2-4].
Although cells usually produce IFNα and β in response
to viral or other infections, the interferons play a role in
the absence of infection as well [5,6]. IFNβ production
by plasmacytoid dendritic cells and Th1 T cells has been
implicated in inhibiting Th2 cell migration in inflamed
lungs in a model of allergic asthma [5]. Furthermore,
low level IFN production has been observed in the ab-
sence of infection both in vivo and in vitro [6]. It has
been proposed that this low level IFN production isd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sponse to infections by priming the cells for further,
rapid IFN responses [6].
Hyaluronan (HA) is a glycosaminoglycan found
throughout the extracellular matrix. It plays a variety of
roles both in maintaining structure and in responding to
injury [7-9]. HA is produced predominantly in fibro-
blasts by three isoforms of hyaluronan synthase, and is
released from the plasma membrane into the extracellu-
lar space [7]. It is abundant in the synovial and vitreous
fluids and makes up 80% of the glycosaminoglycan in
the lung [7]. In a healthy lung, HA exists predominantly
in a high molecular weight form (6 million daltons) that
is important in maintaining distribution of plasma pro-
teins. High molecular weight HA is immunosuppressive
by a variety of mechanisms including enhancing sup-
pressive T regulatory cells, and inhibiting macrophage
phagocytosis [7,10]. However, fragments of HA pro-
duced both by breakdown of high molecular weight
forms and by direct synthesis by hyaluronan synthases
have profound biological activities that diverge from
these pro-homeostatic effects [8,9,11]. In the setting of
tissue destruction, low molecular weight fragments of
hyaluronan (200,000 daltons) accumulate and act as an
endogenous “danger signal”, inducing a host of inflam-
matory mediators [12-15]. These fragments have been
shown to act via TLR2-MyD88-IRAK–PKζ or TLR4-
MyD88 binding to promote the production of inflamma-
tory chemokines, such as MIP-1α, MIP 1β, KC,
RANTES, MCP-1, IP-1, IL-12, IL-8 and TNFα [12-15].
In light of the emerging importance of hyaluronan in
regulating inflammation in response to tissue injury, we
sought to determine its potential role in regulating the
induction of type I interferons. In this report we demon-
strate the ability of HA fragments to promote IFNα and
β expression in the absence of viral infection. Further-
more, our studies reveal a previously unappreciated
MyD88-independent signaling pathway responsible for
HA-induced inflammatory gene expression. Thus, LMW
HA may be modifying the inflammatory milieu simul-
taneously via several pathways.
Methods
Cells
MH-S cells (a murine alveolar macrophage line) or
RAW 264.7 cells (a murine leukemic monocyte/macro-
phage line derived from ascites) were used (ATCC) [16].
Cells were cultured in RPMI or DMEM media with 10%
fetal bovine serum. For experiments, cells were washed
in phosphate-buffered saline and stimulated in RPMI
1640 media with 1% glutamine and penicillin/strepto-
mycin. Thioglycollate-elicted peritoneal macrophages
were lavaged from female C57BL/6, TLR2 null, TLR4
null, TRIF null, TLR3 null (The Jackson Laboratory), orMyD88 null (Akira and Gollenbeck) mice 4 days after
injection of 3 mL sterile thioglycollate (Sigma-Aldrich).
Before use, cells were allowed to adhere overnight in
RPMI 1640 supplemented with 10% heat inactivated
low-LPS FBS and 1% penicillin-streptomycin/glutamine.
To exclude the effects of contaminating LPS on experi-
mental conditions, cell stimulation was conducted in
serum-free RPMI, and in the presence of polymixin B at
10 μg/mL (Sigma-Aldrich) unless LPS was used as a
stimulant. All animal experiments were approved by the
Johns Hopkins Committee on Animal Use and experi-
ments were conducted in accordance with their guide-
lines and regulations.
Chemicals and reagents
Purified LMW HA fragments (free of protein and other
glycosaminoglycans), with a peak molecular weight of
200,000 Da derived from human umbilical cords, were
purchased from Calbiochem. Polymixin B was purchased
from Sigma. Ultrapure LPS was purchased from
InvivoGen. HMW HA was purchased from Genzyme. HA
disaccharides and chondroitin sulfate B were purchased
from Sigma. BX795 was purchased from Axon, Medcom.
RT-PCR
Total RNA was collected in Trizol reagent (Invitrogen),
stored at -20°C. RNA was extracted per manufacturer’s
protocol. Purity and RNA concentration was measured
using a NanoDrop (ThermoScientific). cDNA was pre-
pared using Superscript III (Invitrogen) according to
manufacturer’s protocol. Real Time PCR was done using
an ABI 7900 cycler and commercially available compos-
ite probesets for interferon beta (ABI). Eukaryotic 18S
was used as internal control. Data were presented as fold
induction over unstimulated samples; for knockout mice
experiments, data are presented as fold induction over
wild-type unstimulated samples.
Luciferase
The human IFN-beta promoter luciferase reporter plas-
mid PGL-3-IFN-beta-LUC41 was a kind gift of J. Hiscott
(McGill University, Montreal, Canada). RAW 264.7 cells
were transfected with 0.5 ug of plasmid per 3million
cells using lipofectamine 2000 (Invitrogen); cells were
transfected for 4 hours, then allowed to rest in complete
media overnight and replated in 96 or 12 well plates.
Cells were then rinsed in warmed PBS and stimulated in
serum-free RPMI with polymixin B (Sigma). Luciferase
activity was measured using Bright-Glo (Sigma) and a
microplate reader.
ELISAs
Cell cultures were stimulated with HA for the allotted
time; supernatants were collected and stored at -80°C.
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(PBL) were performed according to manufacturer’s
specifications.
Western blot analysis
10 ug of whole cell lysates were fractionated by SDS-
PAGE (10%), transferred to nitrocellulose membrane,
blocked with 5% milk, washed, and incubated with pri-
mary antibodies to IRF-3 (1:1000) or phospho-IRF3 S396
(1:1000) (Santa Cruz Biotechnology). Secondary anti-
bodies were purchased from GE Healthcare and devel-
oped with a chemiluminescent system according to the
manufacturer’s instructions (Amersham).
Statistics
All statistical analysis was conducted using the Student’s
t-test. Statistically significant values were considered to
be those where p < 0.05.Figure 1 HA fragments induce IFNβ mRNA and protein. (a) MH-S alveo
HA fragments, RNA extracted and Real-Time PCR performed for IFNβ norm
fashion with peak induction at 3 h with a dose 1000 μg/ml. (b) HA fragme
dependent fashion with peak induction at 6 h with a dose of 500 μg/ml. (c
macrophage cell line in a time dependent fashion with peak induction mR
with 200 μg/ml of HA fragments. (e) Thioglycollate elicited primary mouse
fragments (200 μg/ml) for 6 h and IFNβ protein secretion was measured b
experiments done in triplicate. ★ p≤ 0.05 vs. unstimulated.Results
Low molecular weight HA fragments induces IFNβ
In light of the critical role of Type I IFN in regulating in-
fectious and non-infectious immune responses we
sought to determine if endogenous HA fragments could
act as a danger signal by inducing IFNβ in macrophages.
Both alveolar macrophage and peritoneal macrophage
cell lines were stimulated with HA fragments in serum-
free RPMI. Total RNA and protein were isolated, and
analyzed with quantitative PCR or ELISA. HA fragments
induced IFNβ mRNA and protein in a dose-dependent
fashion, with peak protein expression after 500 ug/ml
HA (Figure 1a,b). IFNβ mRNA demonstrated a peak in-
crease at 3 hour and peak protein at 6 h (Figure 1c,d).
Of note, this peak occurred before HA fragment induced
production of other inflammatory cytokines such as
TNF-α, suggesting that the production of IFNβ is a pri-
mary effect of HA, not a downstream effect of TNF-αlar macrophages were stimulated with low molecular weight (LMW)
alized to 18 s. HA fragments induce IFNβ mRNA in a dose dependent
nts induce IFNβ protein in RAW 264.7 macrophages in a dose
,d) HA fragments induce IFNβ RNA and protein in peritoneal
NA at 3 h and protein at 6 h in macrophages; cells were stimulated
macrophages from C57BL/6 WT mice were stimulated with HA
y ELISA. These figures are representative of at least 3-4 identical
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ments to induce IFNβ was observed in primary periton-
eal macrophages indicating that our results were not
confined to cultured cell lines (Figure 1e). Thus, HA
fragments can induce the induction of IFNβ RNA and
protein in both macrophage cell lines and primary
macrophages.
Specific induction of IFNβ by HA fragments
In the lung at rest, HA exists in a high molecular weight
form that plays roles in maintaining tissue integrity and
water homeostasis [7]. We have previously shown that
upon tissue damage the HA is broken down into lower
molecular weight fragments, and that only this form acts
as an endogenous danger signal by activating the innate
immune response [9]. To determine if hyaluronan in-
duction of IFNβ is specific to HA fragments, macro-
phages were stimulated with HA fragments, high
molecular weight HA, or other glycoasminoglycans in
serum free RPMI for 3 hours. Total RNA was then iso-
lated and analyzed by quantitative PCR. As predicted,
HA fragments but not high molecular weight HA in-
duced the production of IFNβ Figure 2). Furthermore,
other glycosaminoglycans such as HA disaccharides,
chrondroitan sulfate A (CSA), and heparin, failed to in-
duce IFNβ mRNA expression (Figure 2).
TLR4 but not TLR2 is required for HA fragment induction
of IFNβ
We have previously demonstrated that HA fragments in-
duce inflammatory cytokines via a TLR2-MyD88-
dependent pathway [9]. Others have implicated TLR4, or
the combination of TLR2 and TLR4 in response to
hyaluronan fragments of various sizes [8,18]. TLR4,
TLR3, and TLR9 are well established as inducers of
IFNβ expression. Although recently vaccinia has been
reported to induce IFNβ via TLR2, in general TLR2 sig-
naling pathways do not induce IFNβ. [19-24]. In some
models TLR2 agonists actually inhibit IFNβ production
[25]. Thus, we wanted to determine which, if any, of theFigure 2 HA fragments induce IFNβ in a specific fashion. RAW
264.7 macrophages were stimulated with LMW HA fragments
(200 μg/ml) for 3 h, RNA extracted and Real-Time PCR performed for
IFNβ. HA fragments but not HMW HA, HA disaccharides,
chondroitan sulfate A (CSA) or heparin induce IFNβ mRNA. This
figure is representative of at least 3 identical experiments done in
triplicate. ★ p≤ 0.01 vs. unstimulated.TLR receptors was involved in mediating HA-induced
IFNβ expression. Thiolglycollate-elicited primary macro-
phages were harvested from TLR2 null, TLR4 null, and
wild type (WT) mice and stimulated in serum-free
media with 200 ug/mL of LMW HA for 3 hours. RNA
was extracted and analyzed by real time quantitative
PCR. Both TLR2 null and WT macrophages responded
briskly to HA fragments, with a marked and significant
increase in IFNβ mRNA. However, the TLR4 null mac-
rophages failed to produce IFNβ after LMW HA sti-
mulation (Figure 3a). In contrast, LMW HA-induced
MIP1α production was reduced in macrophages from
TLR2 null mice but robustly induced by macrophages
lacking TLR4. In addition, macrophages from both TLR2
and TLR4 null mice demonstrated robust expression of
IFNβ in response to poly (I:C), a TLR3 agonist.
TLR2 signaling thus proved to be necessary for the
chemokine expression, but not the IFNβ expression in-
duced by HA fragments. In contrast, TLR4 appeared re-
sponsible for HA-induced IFNβ expression but not
chemokine expression. Thus, the ability of HA frag-
ments to stimulate the C-C chemokine MIP1α and IFNβ
is by two distinct pathways: HA fragments induced che-
mokine expression via TLR2 while the same HA frag-
ments induced type I interferon via TLR4.
To confirm the dependence of HA fragment-induced
IFNβ on TLR4 we employed the pharmacologic inhibitor
CLI-095 [26]. This molecule blocks TLR4 activation
without inhibiting other MyD88-dependent signaling.
Macrophages were pre-incubated with either CLI-095 or
DMSO as a control for 30 minutes, stimulated with HA
fragments or LPS for 3 hours, and then evaluated for
IFNβ expression by RT PCR. Consistent with the ob-
servations in the TLR4 null macrophages, CLI-095
inhibited HA fragment induction of IFNβ mRNA by
80%. As expected, CLI-095 also inhibited TLR4-
dependent LPS induction of IFNβ (Figure 3b). These
data further support the finding that HA fragments in-
duce IFNβ via a TLR4-dependent pathway.
HA fragments induce IFNβ independent of MyD88 via
TRIF
The ability of HA fragments to induce IFNβ in a TLR4
dependent fashion was somewhat surprising. Previously,
it has been shown that LMW HA fragments induced in-
flammatory gene expression via MyD88 [8,9,18]. How-
ever, IFNβ expression via TLR3 and TLR4, proceeds via
MyD88-independent pathways [19,21,22]. Thus, we
sought to determine whether HA fragment induction of
IFNβ is MyD88 dependent. Thiolglycollate-elicited pri-
mary macrophages were harvested from MyD88 null
and wild type mice, stimulated in serum-free media with
200 ug/mL of HA fragments, RNA was extracted and
analyzed with real time PCR. HA fragments induced
Figure 3 HA fragment induction of IFNβ is TLR-4 dependent. (a) Thioglycollate elicited peritoneal macrophages from C57BL/6 WT, TLR2
receptor null or TLR4 receptor null mice were stimulated with 200 ug/mL LMW HA fragments for 3 hours; cells were collected in Trizol, RNA
extracted, and cDNA was analyzed with real-time PCR. HA fragment-induced MIP1α requires TLR2; HA induction of IFNβ was independent of TLR2
but required TLR4. Data demonstrate IFNβ induction compared to WT unstimulated levels; ★ p < 0.05 compared to WT unstimulated; # = p <0.05
compared to genotype specific unstimulated). (b) Pharmacological inhibition of TLR4 significantly decreases HA fragment activation of IFNβ. RAW
264.7 macrophages were prestimulated with 1 ug/mL CLI-095 for thirty minutes, prior to HA fragments (200 ug/ml) or LPS (100 ng/ml) for 3 hours.
Cells were collected in Trizol, RNA extracted, and cDNA was analyzed with real-time PCR. Blocking the TLR4 receptor with CLI-095 significantly
inhibited both HA fragment and LPS induction of IFNβ. Values shown are mean fold induction over WT unstimulated; These figures are representative
of at least 3-4 identical experiments done in triplicate ★ p < 0.05 unstimulated stimulated.
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WT macrophages (Figure 4a). In contrast, the production
of the inflammatory cytokine MIP1α was reduced in the
MyD88 null mice (Figure 4a). These data demonstrate that
HA-induced IFNβ proceeds via a MyD88-independent
pathway, and thus identifies a novel signaling pathway
responsible for HA fragment-induced inflammatory gene
expression.
As IFNβ is known to be induced by TLR3, we wanted
to insure that HA induction of IFNβ via TLR4 was not
also utilizing TLR3 [3]. Therefore, thioglycollate-elicited
primary macrophages were harvested from TLR3 null
and WT mice, stimulated in serum free media with
200 ug/mL of HA fragments for 3 hours, and RNA was
extracted and analyzed with real time PCR. HA fragments
equally induced IFNβ mRNA in both WT and TLR3 null
macrophages (Figure 4b). Thus, HA fragment-induced
IFNβ is not dependent on TLR3.
Since HA did not require MyD88 for induction of IFNβ
via TLR4, we hypothesized that HA fragment-induced
IFNβ expression required the TIR-domain-containing
adapter-inducing interferon-β adaptor protein (TRIF).
Thiolglycollate-elicited primary macrophages were har-
vested from TRIF null and WT mice, stimulated in
serum free media with 200 ug/mL of HA for 3 hours,
RNA was extracted and analyzed with real time PCR.
HA fragment induction of IFNβ mRNA was markedly
reduced in TRIF null macrophages (Figure 4c). In con-
trast, the production of inflammatory cytokine MIP1α
by HA fragments was not affected in the TRIF null
macrophages. Thus, LMW HA induces IFNβ via a
TLR4-TRIF-dependent pathway.
IFNβ is also known to be induced via a TLR-TBK1
pathway [3]. As the TLR3 receptor was not required inour model, we wanted to determine if TBK1 was part of
the HA fragment-induced TLR4-TRIF induction of
IFNβ. Macrophages were stimulated with 200 ug/mL
HA for 3 hours with and without the TBK1 inhibitor
BX795; RNA was isolated and real time PCR performed.
HA fragments and poly(I:C) induced significantly less
IFNβ in the presence of the TBK1 inhibitor (Figure 4d
and e) but HA-induced MIP1α was not significantly
inhibited. Thus, HA induced IFNβ via a TLR4-TRIF-
TBK1 dependent pathway.
HA fragments induce phosphorylation of IRF-3
Interferon response Factor 3 (IRF-3) is central to the
production of interferon beta via the TLR3 and TLR4
pathway, while IRF7 appears to be dominant in the
TLR9 signaling that predominates in plasmacytoid den-
dritic cell [27]. To determine the role of IRF-3 in HA
fragment induction of IFNβ, we performed western ana-
lysis of HA-stimulated macrophages and interrogated
extracts for members of the IRF family. MH-S alveolar
macrophages were stimulated with LMW HA (200 ug/mL)
for 0, 30, 60, 90, and 120 minutes; nuclear extracts were
prepared, and analyzed by western blot with actin as a
loading control. Only IRF-3 was phosphorylated after
HA fragment stimulation, with peak phosphorylation
after 90 minutes (Figure 5a).
To demonstrate the functional consequences of IRF-3
phosphorylation we evaluated the ability of HA to
stimulate an IRF-3-dependent IFNβ-promoter-driven
luciferase reporter construct. Cells were transiently
transfected with the reporter construct and stimulated
with HA fragments for 18 hours prior to cell extract iso-
lation and IFNβ gene activity was determined by lucifer-
ase production. Transfected cells stimulated with LMW
Figure 4 HA fragment induction of IFNβ is independent of MyD88, and TLR3 but dependent upon TRIF and TBK1. Thioglycollate elicited
peritoneal macrophages from WT, MyD88 null, TLR3, TRIF null mice were stimulated with 200 ug/mL LMW HA fragments, LPS 10 ng/ml or p(I:C)
5 ug/ml for 3 hours; cells were collected in Trizol, RNA extracted, and cDNA was analyzed with real-time PCR (a) HA fragments require MyD88 to
induce MIP1α but NOT IFNβ. (b) TLR3 is not necessary for HA induced IFNβ mRNA. (c) In the absence of TRIF, HA fragments induced significantly
less IFNβ. (d,e) RAW macrophages were stimulated with 200 ug/mL HA fragments for 3 hours +/- the TBK1 inhibitor BX795; RNA was isolated and
Real-time PCR performed. HA fragments and p(I:C) induced significantly less IFNβ in the presence of the TBK1 inhibitor but HA induced MIP1α
was not significantly inhibited. Data reported as fold induction over WT unstimulated; data are mean of 3-7 experiments run in triplicate; * p < 0.05 HA
vs US; # p < 0.05 HA vs HA + BX795; p < 0.05 p(I:C) vs p(I:C) + BX795.
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the IFNβ gene (Figure 5b). These functional data sup-
port our model that HA fragments stimulate IFNβ ex-
pression in part through the activation of IRF-3.Discussion
Hyaluronan (HA) is a glycosaminoglycan that plays an
essential role in tissue integrity and water homeostasis
[7]. During inflammation or tissue injury, the normally
high molecular weight HA is broken down into low mo-
lecular weight fragments that induce inflammatory gene
expression in macrophages, dendritic cells, T cells and
epithelial cells [13-15,28]. HA fragments rapidly activate
the innate immune response upon tissue damage even in
the absence of or prior to the establishment of infection.
Thus, we have proposed the HA fragments act as en-
dogenous danger signal [9]. We now demonstrate that
as an early danger signal HA fragments also induce TypeI interferons, which play a critical role in establishing
anti-viral immune responses.
Furthermore, our studies identify an additional signaling
pathway by which HA induces inflammatory gene expres-
sion. While it had previously been shown that HA frag-
ments induced inflammatory gene expression is
dependent upon MyD88 signaling, we now demonstrate a
novel MyD88-independent TLR4-TRIF-TBK1 pathway for
HA fragments induced IFNβ expression [9] (Figure 6).
Thus our studies not only expand our understanding of
the breadth of the inflammatory program induced by HA
but also the intracellular signaling pathways employed by
this endogenous inflammatory mediator. Our data further
highlight the ability of this matrix component to modify
the inflammatory milieu simultaneously via several dis-
tinct pathways.
Hyaluronan is produced by three isoforms of hyaluronan
synthases and released from the plasma membrane into
the extracellular space predominantly by fibroblasts [29].
Figure 5 HA fragments activate IRF-3 phosphorylation and
IFNβ gene activity. (a) MH-S macrophages were stimulated with
LMW HA fragments, nuclear extracts were collected and analyzed for
phosphorylated IRF-3 via Western blot. (b) RAW 264.7 macrophages
were transfected with human IFNβ promoter driven luciferase
construct and stimulated with HA fragments for 18 hours prior to
luciferase measurement. HA fragments induce the IFNβ promoter by
over 2 fold. These data are representative of three identical
experiments. * p < 0.02 vs unstimulated.
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80% of the glycosaminoglycan in the lung [7,10,30]. In a
healthy lung, HA exists predominantly in a high molecular
weight form that is immunosuppressive by a variety of
mechanisms; it enhances suppressive T regulatory cells,Figure 6 HA fragment induced inflammatory gene via distinct
pathways. Schema of the pathways by which LMW HA fragments
induces inflammatory genes via TLR2-MyD88-IRAK1-TRAF6-PKCζ-NK-κB
or via TLR4-TRIF-TBK1-IRF3.inhibits macrophage phagocytosis, and is important in
maintaining distribution of plasma proteins [7,10,30,31].
However, low molecular weight fragments of HA pro-
duced both by breakdown of high molecular weight forms
and by direct synthesis, have profound biological effects
that oppose these pro-homeostatic effects [8,9,11]. The
accumulation of HA fragments is itself a nonspecific
response to lung injury.
Increased levels of HA fragments in the lung, at levels
similar to the doses used in these experiments, are asso-
ciated with a diverse set of injuries including ventilator-
induced lung injury, and bleomcyin and ozone exposure
[32-36]. Mice lacking CD44, a major receptor for HA,
have impaired clearance of HA fragments, and increased
bleomcyin injury [11]. HA fragments instilled into the
lung increases airway hyper-responsiveness in a CD44-
dependent manner [33]. HA fragments have been shown
to mediate airway hyper-responsiveness seen with ozone
exposure through both CD44 and TLR4 [33]. HA frag-
ments promote production of inflammatory chemokines:
MIP1α, MIP1β, KC, RANTES, MCP-1 and IP-10, as well
as cytokines such as IL-8, IL-12 and TNF, via TLR2-
MyD88-IRAK–PKζ binding [12-15]. In the bleomycin
model of lung injury, mice lacking TLR2 are protected,
while TLR2/TLR4 double null mice have increased mor-
tality, suggesting that HA fragment-TLR2/TLR4 interac-
tions have complex downstream effects [8,37,38]. The
complete actions of HA fragments in the lung and other
sites of tissue injury are still incompletely understood.
The generation of type I interferons is important not
only locally but also systemically to condition and recruit
immune cells to the site of infection [39]. The recogni-
tion of viral components and release of interferons is
known to be mediated by TLR3, TLR7,TLR8 and TLR9
signaling as well as by more recently defined receptors
such as RIG-I, MDA5 and DAI [39]. In addition, TLR4
signaling (for example by LPS) can lead to interferon
production in a pathway dependent on STAT1 and the
transcription factor IRF-3 [3]. TLR4 also uses an
additional adaptor protein, TRAM, which seems to
be unique to TLR4-induced interferon production
[3,19,27,40]. In contrast, TLR2 ligands in general do not
appear to phosphorylate STAT1 or lead to significant
production of interferon beta in the majority of cases
[3,19,23,27,40]. Here we demonstrate that LMW HA can
increase production of IFNβ. This effect is not via the abil-
ity of LMW HA to activate TLR2 (as has been previously
described) but rather by TLR4 activation. Furthermore,
unlike other LMW HA signaling, LMW HA-induced
TLR4 activation depends on TRIF and not MyD88.
In a study on the effects of HA on neutrophils, Leu et al.
observed that apoptosis of neutrophils is decreased in
TLR4 null mice [41]. They demonstrated that was due to
IFNβ mediated TRAIL-TRAILR interactions, as the
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inflammatory neutrophils. Administration of intratracheal
HA fragments (2000 ug/ml) was found to result in an in-
crease in IFNβ in whole lung neutrophils, an effect that
was mitigated in the TLR4-/- mice. Our studies now pro-
vide a biochemical mechanism for these observations. Our
data demonstrate that LMW HA directly induces IFNβ
production and that this occurs via a newly defined TLR4-
TRIF-TBK1-IRF3 pathway. Thus, tissue damage causing
fragmentation of matrix hyaluronan generating local high
concentrations of HA fragment-induced IFNβmay
prime the innate response for a potential viral infection
(Figure 6), expanding the range of the ‘danger signal’
properties of LMW HA. The induction of IFNβ by HA,
an endogenous danger signal, raises the possibility that
the anti-viral effects of the interferons may be triggered
early in injury, perhaps priming the immune system to
launch a full anti-viral program.
Alternatively, the production of IFNβ may be intended
to modify the pro-inflammatory effects of HA. Although
the type I interferons are best known for their effects in
viral infection, they also have the ability to inhibit in-
flammatory responses [6]. For example, in the eye, IFNβ
appears to be important in suppressing inflammatory
responses; IFNβ is produced in substantial amounts by
retinal pigmented epithelial cells, and eliminates produc-
tion of T cell chemoattractant CXCL9 in response to
TNFα/ IFNg/IL-1β [42]. Moreover, in a murine model,
the increase in type I interferon ten days after influenza
infection led to significantly decreased neutrophilic re-
sponses to subsequent bacterial pneumonia and in-
creased mortality [43]. Therefore, HA induced activation
of IFNβ via TLR4-TRIF-TBK1 may also act as a potential
brake for innate inflammatory responses. Taken together,
a model emerges whereby immediate tissue damage can
lead to HA fragment-induced IFNβ that primes the in-
nate response for a potential viral infection (Figure 6).
Alternatively, persistent tissue damage leading to the ac-
cumulation of HA fragments may in fact serve to down
regulate certain inflammatory responses. Thus this novel
downstream effect of HA expands the role of this en-
dogenous danger signal, and opens avenues for further
investigation. In addition, the redundancy of inflamma-
tory pathways triggered by LMW HA may also add to
the robustness of an inflammatory response.
Conclusions
Low molecular weight fragments of the extracellular
matrix component hyaluronan use many pathways to acti-
vate the immune system and modulate inflammation. We
demonstrate a novel CD44 and MyD88 independent path-
way for HA fragments to activate macrophage production
of interferon-β via TLR4-TRIF-TBK1-IRF3. Our data im-
plicate HA fragment-induced interferons resulting fromtissue damage as a novel potential endogenously derived
warning system initiating an anti-viral response prior to
the establishment of infection. Furthermore, this HA-
induced gene expression is the result of a newly defined
HA fragment downstream signaling pathway.
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